Shao Hanshuang, Chou Jeff, Baty Catherine J, Burke Nancy A, Watkins Simon C, Stolz Donna Beer, Wells Alan
Department of Pathology, University of Pittsburgh, Scaife Hall, S-711, 3550 Terrace St., Pittsburgh, PA 15261, USA.
Mol Cell Biol. 2006 Jul;26(14):5481-96. doi: 10.1128/MCB.02243-05.
Calpain activity is required for de-adhesion of the cell body and rear to enable productive locomotion of adherent cells during wound repair and tumor invasion. Growth factors activate m-calpain (calpain 2, CAPN2) via ERK/mitogen-activated protein kinases, but only when these kinases are localized to the plasma membrane. We thus hypothesized that m-calpain is activated by epidermal growth factor (EGF) only when it is juxtaposed to the plasma membrane secondary to specific docking. Osmotic disruption of NR6 fibroblasts expressing the EGF receptor demonstrated m-calpain being complexed with the substratum-adherent membrane with this increasing in an EGF-dependent manner. m-Calpain colocalized with phosphoinositide biphosphate (PIP(2)) with exogenous phospholipase C removal of phosphoinositides, specifically, PI(4,5)P(2) but not PI(4)P(1) or PIP(3), releasing the bound m-calpain. Downregulation of phosphoinositide production by 1-butanol resulted in diminished PIP(2) in the plasma membrane and eliminated EGF-induced calpain activation. This PIP(2)-binding capacity resided in domain III of calpain, which presents a putative C2-like domain. This active conformation of this domain appears to be partially masked in the holoenzyme as both activation of m-calpain by phosphorylation at serine 50 and expression of constitutively active phosphorylation mimic glutamic acid-increased m-calpain binding to the membrane, consistent with blockade of this cascade diminishing membrane association. Importantly, we found that m-calpain was enriched toward the rear of locomoting cells, which was more pronounced in the plasma membrane footprints; EGF further enhanced this enrichment, in line with earlier reports of loss of PIP(2) in lamellipodia of motile cells. These data support a model of m-calpain binding to PIP(2) concurrent with and likely to enable ERK activation and provides a mechanism by which cell de-adhesion is directed to the cell body and tail as phospholipase C-gamma hydrolyzes PIP(2) in the protruding lamellipodia.
在伤口修复和肿瘤侵袭过程中,细胞体和尾部的去黏附对于贴壁细胞的有效运动是必需的,而钙蛋白酶活性参与其中。生长因子通过ERK/丝裂原活化蛋白激酶激活m-钙蛋白酶(钙蛋白酶2,CAPN2),但只有当这些激酶定位于质膜时才会激活。因此,我们推测只有当表皮生长因子(EGF)通过特定对接作用与质膜并列时,m-钙蛋白酶才会被激活。对表达EGF受体的NR6成纤维细胞进行渗透压破坏,结果显示m-钙蛋白酶与黏附于基质的膜形成复合物,且这种复合物的形成以EGF依赖的方式增加。m-钙蛋白酶与磷脂酰肌醇二磷酸(PIP(2))共定位,外源性磷脂酶C去除磷脂酰肌醇后,特别是PI(4,5)P(2)而非PI(4)P(1)或PIP(3),可释放结合的m-钙蛋白酶。1-丁醇下调磷脂酰肌醇的产生会导致质膜中PIP(2)减少,并消除EGF诱导的钙蛋白酶激活。这种PIP(2)结合能力存在于钙蛋白酶的结构域III中,该结构域呈现出一个假定的C2样结构域。在全酶中,该结构域的这种活性构象似乎部分被掩盖,因为丝氨酸50处的磷酸化激活m-钙蛋白酶以及组成型活性磷酸化模拟物谷氨酸的表达都会增加m-钙蛋白酶与膜的结合,这与该级联反应的阻断减少膜结合一致。重要的是,我们发现m-钙蛋白酶在运动细胞的尾部富集,在质膜足迹中更为明显;EGF进一步增强了这种富集,这与早期关于运动细胞片状伪足中PIP(2)减少的报道一致。这些数据支持了一个模型,即m-钙蛋白酶与PIP(2)结合的同时可能会激活ERK,并提供了一种机制,通过该机制,当磷脂酶C-γ水解突出的片状伪足中的PIP(2)时,细胞去黏附被导向细胞体和尾部。